Bi Yonghua, Wu Zhengyang, Yi Mengfei, Han Xinwei, Ren Jianzhuang
Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No.1, East Jian She Road, Zhengzhou, 450052, China.
BMC Gastroenterol. 2020 Oct 7;20(1):330. doi: 10.1186/s12876-020-01480-z.
Anastomotic leakage is common and life-threatening complication after esophagectomy. The management of esophageal anastomotic leakage remains challenging. We aimed to determine the safety, feasibility and efficacy of three-tube method and covered metallic stent placement for the management of anastomotic leakage.
Twenty-six consecutive patients with anastomotic leakage were treated using three-tube method and covered metallic stent and the medical records were retrospectively assessed. All patients received placement of abscess drainage tube, jejunal feeding tube and gastrointestinal decompression tube as well as esophageal covered stent, followed by continue abscess drainage, nutritional support and anti-inflammatory treatment. Tubes and esophageal stents will be removed once anastomotic leakage heals.
The procedure was technically successful in 23 patients (95.8%). A total of 31 covered stents were used. Esophageal stents and abscess drainage tubes were successfully removed from 14 patients. The median retention duration was 2.3 months and 2.6 months for stent and abscess drainage tubes, respectively. No perioperative death, esophageal rupture, massive hemorrhage, or other severe complications were observed during procedures. The abscess cavity had markedly decreased in 8 patients or disappeared in 16 cases. During follow-up, 8 patients died of cancer recurrence and 2 patients died of severe pulmonary infection. The 1-, 3-, 5-year survival rates were 60.1, 51.5 and 51.5%, respectively.
Three-tube method and covered metallic stent placement is safe, feasible and efficacious for treatment of anastomotic leakage after esophagectomy.
吻合口漏是食管癌切除术后常见且危及生命的并发症。食管吻合口漏的处理仍然具有挑战性。我们旨在确定三管法和带膜金属支架置入术治疗吻合口漏的安全性、可行性和有效性。
对连续26例吻合口漏患者采用三管法和带膜金属支架治疗,并对病历进行回顾性评估。所有患者均放置脓肿引流管、空肠营养管和胃肠减压管以及食管带膜支架,随后持续进行脓肿引流、营养支持和抗炎治疗。吻合口漏愈合后即拔除各引流管和食管支架。
该操作在23例患者(95.8%)中技术成功。共使用了31个带膜支架。14例患者成功拔除食管支架和脓肿引流管。支架和脓肿引流管的中位留置时间分别为2.3个月和2.6个月。术中未观察到围手术期死亡、食管破裂、大出血或其他严重并发症。8例患者脓肿腔明显缩小,16例患者脓肿腔消失。随访期间,8例患者死于癌症复发,2例患者死于严重肺部感染。1年、3年、5年生存率分别为60.1%、51.5%和51.5%。
三管法和带膜金属支架置入术治疗食管癌切除术后吻合口漏安全、可行且有效。